$BWA

BorgWarner Boosts FY26 EPS, Adj. EPS Outlook - Update

BorgWarner (BWA) reported Q2 results and raised its FY2026 adjusted EPS outlook while keeping sales guidance. For FY26, it now expects net sales of $14.0B to $14.3B and adjusted EPS of $5.05 to $5.30 (previously $5.00 to $5.20). It also projects EPS of $4.72 to $4.94. Shares were up premarket.

Original reporting
Published Aug 5, 2026, 2:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 3:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
BorgWarner Boosts FY26 EPS, Adj. EPS Outlook - Update — source image
Decision brief

The 30-second read

$BWABullishMed
01

Why it matters

The key new information is the raised FY2026 adjusted EPS range, which can re-anchor expectations for the rest of the year while sales guidance remains unchanged.

02

Market read

A guidance increase with specific EPS and sales ranges is a direct catalyst for valuation and positioning ahead of subsequent quarters.

03

What to watch

The article does not break down what changed (margins, mix, costs, or FX), so traders should verify the earnings release for the drivers behind the EPS increase.

Relevance 8/10Novelty 7/10Timing: pre-market today after Q2 results and FY26 guidance update

Background

BorgWarner reported Q2 results and updated its full-year 2026 earnings outlook.

Company-level read

Ticker impact

$BWABullishMedium confidence
Context

BorgWarner raised FY2026 adjusted EPS guidance to $5.05 to $5.30 while keeping net sales outlook at $14.0B to $14.3B.

Expected impact

Likely supportive for the stock in the near term, with follow-through dependent on whether organic sales decline stays within the guided range.

Evidence & confidence

The article discloses a specific, incremental guidance increase for FY2026 adjusted EPS, which is a direct earnings catalyst; however, it also notes organic sales decline remains in a similar band, limiting upside certainty.

Market effects

Signals resilience in industrial auto-supply earnings expectations, potentially improving sentiment for auto parts and solutions providers.

Primarily US-listed industrial sentiment; limited direct regional spillover described.

No explicit global macro or cross-border transaction details beyond company-wide FY outlook.

Counterpoint

The guidance raise may be offset by continued organic sales decline, so the market may focus on whether the higher EPS is driven by temporary factors rather than durable demand.

Key entities

  • BorgWarner, Inc.

    Raised FY2026 adjusted EPS guidance to $5.05 to $5.30 while maintaining net sales outlook.

Related articles

$BWAMed

BorgWarner secures new VCT engine contracts in Europe and China

BorgWarner said it won new variable cam timing (VCT) programme awards for its center-bolt Cam Torque Actuated (CTA) system. In Europe, it received a life extension and a “significant” volume increase for a premium carmaker’s V6 engine family, starting Jan 2027. In China, it won a conquest award for a 1.5L turbo petrol engine family, replacing the prior supplier, with production starting Sept 2026.

$BWAMed

BorgWarner Inc. Q2 2026 Earnings Call Summary

BorgWarner reported Q2 2026 adjusted margin expansion of 100 bps despite flat sales, citing cost controls and operational efficiency. The company said EPS rose 17% on improved operating income and about $650m in share repurchases over four quarters. It expects 2027 turbine generator revenue of $300m and 2 GW capacity, plus battery systems production readiness by 2027, with guidance including a 170 bps battery headwind.

$BWAHighAI 9/10

Why is BorgWarner stock surging today?

BorgWarner (BWA) shares rose about 7% pre-open after the company reported Q2 adjusted EPS of $1.42 vs $1.27 expected and revenue of $3.65B vs $3.57B. BorgWarner raised FY2026 guidance to $5.05-$5.30 per share and expanded its buyback authorization by $1B to about $1.35B through 2029, citing margin improvement and cost control.

$BWAMed

BORGWARNER INC (BWA): Results of Operations and Financial Condition

BORGWARNER INC (BWA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a20260630ex991pressrelease.htm EX-99.1 Document Exhibit 99.1 Immediate Release Contact: Patrick Nolan 248.754.0884 BorgWarner Reports Strong Second Quarter 2026 Results Increases 2026 Adjusted EPS Guidance and Share Repurchase Authorization By $1 Billion Announces 7 Awa